Opinion; The right incentives for global vaccine access

Michele Goodwin, UCI Chancellor’s Professor of law and Gregory Shaffer, UCI Chancellor’s Professor of law write, “The question is how to compel pharmaceutical companies to provide their trade secrets to other manufacturers to produce the vaccines, subject to a nondisclosure agreement and compensation on a cost or cost-plus basis. The threat of an IP waiver could encourage and compel pharmaceutical companies to enter into such arrangements.”